IMPROVING EMERGENCY CARE EXPERIENCES FOR YOUNG PEOPLE THROUGH HUMAN-CENTRED DESIGN
With
Melanie Tran,
Manager (Digital, Design & Data)
Nous Group
PEOPLE IN HEALTH CARE SEGMENT
Filmed in Sydney | October 2025
Recognised as one of the Top 100 Women of Influence by The Australian Financial Review, Melanie Tran is a visionary leader whose work lies at the intersection of design, technology, health, disability, and education. With a focus on human-centred design, digital strategy, and service design, she leads transformative initiatives as a Manager in Design, Digital and Data at Nous Group, a global consulting firm. Her work is driven by a deep passion for using creativity and technology to solve complex social challenges.
At the heart of Melanie’s work is her dedication to leveraging creativity and technology to address some of society’s most pressing challenges. She is currently pursuing a PhD at Torrens University Australia, where her research focuses on using human-centred design and technology to improve the patient experience for young people in emergency departments at children’s hospitals.
Melanie’s achievements have garnered national and international recognition. She is a recipient of prestigious awards and fellowships such as the Laureate Global Fellowship, the Laureate Global Here for Good Award, the Recalibrate Gender Equality Award, and the Distinguished Social Change Leader Award.
As an accomplished public speaker, Melanie has shared her insights on global platforms, including the Vogue Codes Summit, Cognizant Technology Solutions Conference, TEDxSydney Pitch Night, and the Women in Leadership Symposium. She has also spoken at the Laureate Global Leadership Summit, Reimagination Thought Leaders Summit at the Australian Computer Society, and the United States Sustainable Development Goals Action Zone Conference. Notably, she delivered the keynote address at Google’s first-ever Asia Pacific UX Design Summit, further solidifying her position as a leading voice in design and technology.
Melanie spoke with Australian Health Journal at MedTech25, following her keynote address at the annual Medical Technology Association of Australia conference.
Source: Supplied
You Might also like
-
Sovereign capability uplifted
Skilled labour, in particular skilled in the manufacture of MTP products, namely competency in Good Manufacturing Practice (GMP), was identified as one of the key priorities, according to Jarrod Belcher, Director of the REDI Program at MTPConnect. Through a competitive process, MTPConnect selected additional industry training providers to deliver new programs addressing key skills gaps in the sector workforce.
Launched in September 2022, one of these programs is GMP Uplift developed by the Centre for Biopharmaceutical Excellence (CBE). CBE bring experience across large and small Biologics, Pharmaceuticals and Regenerative Medicine companies, both in consulting and GMP related enterprise training. CBE staff also have extensive experience in GMP operations, compliance, auditing and QMS design, a wide industry network for guest lecturers and readily available case studies.
-
Diversity, inclusion and equity New Content Orthopaedic Surgeon People in healthcare Workforce growth
Supporting women in arthroplasty, surgery & orthopaedic oncology
Associate Professor Claudia Di Bella is an academic orthopaedic surgeon based in Melbourne, specialising in orthopaedic oncology and complex joint reconstruction. Originally trained at the world-renowned Rizzoli Orthopaedic Institute (Istituto Ortopedico Rizzoli) in Bologna, Italy, she moved to Australia in 2010 and was awarded Fellowship of the Royal Australasian College of Surgeons in 2013.
-
Foundation outlines breast cancer research strategy
Australian Health Journal met with Associate Professor Cleola Anderiesz, CEO of the National Breast Cancer Foundation to hear of the new 5 year Pink Horizon research strategy. Those with lived experience of breast cancer, along with researchers, clinicians, and other funding organisations, have contributed to the development of the foundation’s new five-year Pink Horizon research strategy. This ambitious plan aims to invest $125 million to accelerate research efforts towards the vision of ending deaths from breast cancer.